References
- Fisher R I, De Vita V T, Hubbard S M, et al. Diffuse aggressive lymphomas: increased survival after alternating flexible sequences of promace and MOPP chemotherapy. Ann Intern Med 1983; 98: 304–309
- Skarin A T, Canellos G P, Rosenthal D S, et al. Improved prognosis of diffuse histiocytic and undifferentiated lymphoma by use of high dose methotrexate alternating with standard agents (M-BACOD). J Clin Oncol 1983; 1: 91–98
- Klimo P, Connors J M. MACOP-B chemotherapy for the treatment of diffuse large-cell lymphoma. Ann Intern Med 1985; 102: 596–602
- Cabanillas F, Hagemeister F B, McLaughlin P, et al. Results of MIME salvage regimen for recurrent or refractory lymphoma. J Clin Oncol 1987; 5: 407–412
- Velasquez W, Cabanillas F, McLaughlin P, et al. Combination of cisplatin-Ara-C and decadron in relapsing lymphoma (abstr). Proc Am Soc Clin Oncol 1986; 5: 191
- O'Donnell M R, Forman S J, Levine A M, et al. Cytarabine, cisplatin and etoposide chemotherapy for refractory non-Hodgkin's lymphoma. Cancer Treat Rep 1987; 71: 187–189
- Appelbaum F R, Sullivan K M, Buckner C D, . Treatment of malignant lymphoma at first relapse or second remission with marrow transplantation Autologous Bone Marrow Transplantation. Proceeding of the Third International Symposium, K A Dicke, G Spitzer, S Jagannath, et al. The University of Texas, MD Anderson Hospital and Tumor Institute at Houston, Houston 1987; 275–277
- Appelbaum F R, Sullivan K M, Buckner C D, et al. Marrow transplantation as treatment for patients with recurrent malignant lymphoma. Int J Cell Clon 1985; 3: 216–217
- Jagannath S, Dicke K A, Armitage J O, et al. High dose cyclophosphamide, carmustine and etoposide and autologous bone marrow transplantation for relapsed Hodgkin's disease. Ann Intern Med 1986; 104: 163–168
- Gulati S C, Shank B, Black P, . Optimum timing of autologous bone marrow transplantation for patients with large B cell lymphomas. Autologous Bone Marrow Transplantation, Proceeding of the Third International Symposium, K A Dicke, G Spitzer, S Jagannath, et al. The University of Texas, MD Anderson Hospital and Tumor Institute at Houston, Houston 1987; 275–277
- Warrell R P, Lee B J, Kempin S J, et al. Effectiveness of methyl-Gag in patients with advanced malignant lymphoma. Blood 1981; 57: 1011–1014
- Kantarjian H, Barlogie B, Plunkett W, et al. High dose cytosine arabinoside in non Hodgkin's; lymphoma. J Clin Oncol 1983; 1: 684–694
- Cabanillas F. Amsacrine: current perspectives and clinical results with a new anti-cancer agent. Proceedings of an International Symposium on AMSACRINE. Communications Media for Education. INC, Princeton Junction, NJ 1982; 55
- Rodriguez V, Mc Credie K B, Keating M J, et al. Ifosfamide therapy for hematologic malignancies in patients refractory to prior treatment. Cancer Treat Rep 1978; 62: 493–497
- Cabanillas F, Velasquez W S, Jagannath S, . Recent results with salvage chemotherapy for recurrent lymphoma. Autologous Bone Marrow Transplantation. Proceeding of the Third International Symposium, K A Dicke, G Spitzer, S Jagannath, et al. The University of Texas, MD Anderson Hospital and Tumor Institute at Houston, Houston 1987; 243–247
- The Non-Hodgkin's Lymphoma Pathologic Classification Project National Cancer Institute sponsored study of classification of non-Hodgkin's lymphoma: Summary and description of a working formulation for clinical usage. Cancer 1982; 49: 2112–2135
- Miller A B, Hoogstraten B, Staquet M, et al. Reporting results of cancer treatment. Cancer 1981; 47: 207–214
- Philip T, Armitage J, Spitzer G, . An International randomized study of relapsed diffuse intermediate and high grade lymphomas in adults. Autologous Bone Marrow Transplantation. Proceeding of the Third International Symposium, K A Dicke, G Spitzer, S Jagannath, et al. The University of Texas, MD Anderson Hospital and Tumor Institute at Houston, Houston 1987; 313–333